Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fukeyangrong capsules (also known as Fukeyangrong Jiaonang) is a traditional Chinese patent medicine formulated with 16 herbal ingredients, including Angelica sinensis (Danggui), Atractylodes macrocephala (Baizhu), Rehmannia glutinosa (Shudihuang), Ligusticum chuanxiong (Chuanxiong), and Leonurus japonicus (Yimucao). It is traditionally used to nourish qi and blood, soothe the liver, resolve stasis, and regulate menstruation. Clinically, Fukeyangrong capsules are utilized to treat female infertility, diminished ovarian reserve, irregular menstruation, dizziness, and anemia. The General Hospital of Ningxia Medical University has evaluated the capsules in a Phase 4 clinical trial for infertility associated with diminished ovarian reserve, both as a monotherapy and in combination with hormone replacement therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fukeyangrong capsules.